• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRANCHBURG STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRANCHBURG STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 2025002
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Adhesion(s) (1695); Hernia (2240); Obstruction/Occlusion (2422)
Date of Event 08/01/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2022.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Additional Manufacturer Narrative
The lot associated with this event was not reported and remains unknown; therefore a review into the device history records could not be performed.No strattice devices were returned for evaluation.Based on the limited information, and without relevant patient factors, a relationship between the event and the strattice could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
Additional and/or corrected data.
 
Event or Problem Description
This is follow up#1 to report on 16/jul/2024, pmqa received notification from legal that the plaintiff profile form was received associated with this event.As per the ppf form, the patient underwent a ¿parastomal¿ hernia surgery and was implanted with an unknown strattice device on (b)(6) 2022.The patient underwent a ¿robotic assisted laparoscopic incarcerated incisional ventral hernia with mesh measuring 9 cm x 3 cm; robotic assisted laparoscopic recurrent incarcerated incisional ventral hernia repair with mesh measuring 4 cm x 2.5 cm; robotic lysis of abdominal adhesions for 1 hour; robotic explantation of prior hernia mesh¿ on (b)(6) 2023.As per the ppf form, the patient claims the implantation and failure of the mesh caused the following injuries: ¿pain and suffering, physical injury, loss of enjoyment of life and economic and non-economic losses as a result of [their] strattice implant.¿ patient ¿suffers from abdominal tenderness.¿ patient ¿is dependent on others to help with daily tasks [they have] difficulty completing [themselves].¿ patient ¿has lifting restrictions and had to adjust [their] physical activities.¿ patient ¿has difficulty walking long distances, bending, and doing yard work.¿ patient ¿has difficulty participating in family activities.¿ patient¿s ¿stomach is scarred and disfigured which causes [them] embarrassment.¿ patient ¿wears an uncomfortable abdominal binder.¿ patient " is fearful [they] will suffer another hernia.¿ ¿these injuries contribute to [the patient¿s] anxiety and depression.¿ the form lists the conditions that were treated were ¿sigmoid resection with coloproctostomy; colostomy takedown with transverse colon resection & side-to-side functional end anastomosis; repair of parastomal hernia with mesh 20 x 25 cm; extensive lysis of adhesions; bilateral ureteral stent removal; seprafilm applied to anterior bowel wall just below fascial closure; wound vac¿ between on (b)(6) 2022.The patient underwent ¿robotic assisted laparoscopic incarcerated incisional ventral hernia repair with mesh measuring 9 cm x 3 cm; robotic assisted laparoscopic recurrent incarcerated incisional ventral hernia repair with mesh measuring 4 cm x 2.5 cm; robotic lysis of abdominal adhesions; robotic explantation of prior hernia mesh¿ on or about on (b)(6) /2023.The patient has received treatment for ¿anxiety & depression¿ from 2021 to present.The ppf form also indicates that the patient was implanted with two non-abbvie devices, ¿covidien symbotex lot#: pxc0100x, covidien symbotex mesh lot#: pxc2106x¿ on (b)(6) 2023.The form indicates that the device was not removed or revised.As reported in the initial: limited information was reported through a legal event that a patient was implanted with strattice firm on (b)(6) 2022.The form also indicates that on an unspecified date, the strattice implant had been ¿removed or revised¿.No information was provided on the indication for the initial surgery or the reason for the removal or revision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 25, FIRM
Common Device Name
MESH, SURGICAL
Manufacturer (Section D)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer (Section G)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer Contact
christopher belle
1 millennium way
branchburg, NJ 08876
9089471470
MDR Report Key19248830
Report Number1000306051-2024-00107
Device Sequence Number20482652
Product Code FTM
UDI-Device Identifier00818410010157
UDI-Public00818410010157
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K070560
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number2025002
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/01/2024
Supplement Date Received by Manufacturer07/16/2024
Initial Report FDA Received Date05/06/2024
Supplement Report FDA Received Date07/22/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient SexFemale
-
-